|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.93 USD | -2.14% |
|
+2.30% | -2.14% |
| 11:59am | AstraZeneca shares fall 9% as cardiovascular drug Wainua fails test | AN |
| 11:37am | The failure of a clinical trial sends AstraZeneca shares tumbling |  |
| Market Cap | 295B 259B 239B 221B 419B 28,262B 427B 2,873B 1,116B 13,830B 1,108B 1,084B 48,011B | P/E 2026 * |
23.8x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 314B 276B 255B 235B 446B 30,112B 455B 3,061B 1,189B 14,736B 1,181B 1,155B 51,153B | EV / Sales 2026 * |
4.98x | EV / Sales 2027 * | 4.59x |
| Free-Float |
96.63% | Yield 2026 * |
1.75% | Yield 2027 * | 1.85% |
Last Transcript: AstraZeneca PLC
| 1 day | -2.14% | ||
| 1 week | +2.30% | ||
| Current month | -0.47% | ||
| 1 month | +3.10% | ||
| 3 months | -7.68% | ||
| 6 months | +0.53% | ||
| Current year | -2.14% |
| 1 week | 47.8 |  | 50 |
| 1 month | 43.66 | | 50.6 |
| Current year | 43.66 | | 53.8 |
| 1 year | 34.55 | | 53.8 |
| 3 years | 29.05 | | 53.8 |
| 5 years | 28 | | 53.8 |
| 10 years | 28 | | 53.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.14% | +2.30% | - | - | 295B | |
| -1.60% | +2.02% | +56.34% | +168.94% | 1,084B | |
| -1.44% | +3.71% | +69.07% | +65.40% | 634B | |
| -0.75% | +0.67% | +33.18% | +86.52% | 447B | |
| -0.57% | -2.28% | +28.35% | +25.81% | 330B | |
| -0.64% | -2.14% | +28.43% | +46.05% | 285B | |
| -0.70% | -2.92% | -27.25% | -39.29% | 218B | |
| -0.03% | +1.84% | +23.90% | +68.30% | 199B | |
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | |
| -0.08% | +0.71% | -6.13% | -32.31% | 137B | |
| Average | -0.83% | +2.29% | +25.35% | +52.44% | 389.09B | |
| Weighted average by Cap. | -1.11% | +2.38% | +39.66% | +85.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.19B 55.42B 51.17B 47.28B 89.62B 6,050B 91.41B 615B 239B 2,961B 237B 232B 10,278B | 66.84B 58.63B 54.12B 50.02B 94.8B 6,400B 96.7B 651B 253B 3,132B 251B 246B 10,872B |
| Net income | 12.45B 10.92B 10.08B 9.32B 17.66B 1,192B 18.01B 121B 47.1B 583B 46.76B 45.74B 2,025B | 13.96B 12.25B 11.3B 10.45B 19.8B 1,337B 20.2B 136B 52.81B 654B 52.43B 51.28B 2,271B |
| Net Debt | 19.32B 16.94B 15.64B 14.46B 27.4B 1,850B 27.95B 188B 73.07B 905B 72.55B 70.96B 3,142B | 11.81B 10.36B 9.56B 8.84B 16.75B 1,131B 17.08B 115B 44.66B 553B 44.34B 43.37B 1,921B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | $48.93 | -2.14% | 80 |
| 03/07/26 | $50.00 | -0.20% | 1 |
| 02/07/26 | $50.10 | +4.75% | 505 |
| 01/07/26 | $47.83 | -2.71% | 1 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZND Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
